NCT00308191View on ClinicalTrials.gov

A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

December 31, 2006

Conditions
COPD
Interventions
DRUG

Formoterol Fumarate

DRUG

Tiotropium Bromide

Trial Locations (17)

13088

Research Site, Liverpool

14618

Research Site, Rochester

19426

Research Site, Collegeville

30501

Research Site, Gainesville

33321

Research Site, Tamarac

48105

Research Site, Ann Arbor

48152

Research Site, Livonia

63141

Research Site, St Louis

78229

Research Site, San Antonio

79902

Research Site, El Paso

80907

Research Site, Colorado Springs

85006

Research Site, Phoenix

90095

Research Site, Los Angeles

91343

Research Site, Sepulveda

94598

Research Site, Walnut Creek

97504

Research Site, Medford

04210

Research Site, Auburn

All Listed Sponsors
lead

Dey

INDUSTRY

NCT00308191 - A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD | Biotech Hunter | Biotech Hunter